28th – 29th September, 2011 9:00 – 18:00 / 9:00 – 16:00
Meeting Venue: Potsdam, Germany
28th – 29th March, 2011 9:30 – 18:00 / 9:00 – 16:00
Meeting Venue: Spain, Universitat de Barcelona
During the third year the Consortium has completed the prototype of the Chronious system. After a successful phase of system integration and preliminary technical tests CHRONIOUS prototypes were ready to pass to the subsequent step: the clinical validation in humans. The preliminary test have been conducted in protected conditions taking advantage of the facilities of the Feltre and Careggi Hospitals, in Italy, to detect and prevent critical situations and clinical instability that could occur at home. This is the reason why we paid particular attention and spend long time to the phase A. Clinical personnel and technicians collaborated strongly to set up the system, involve the patients and draw out the results. The first phase of validation helped the CHRONIOUS Consortium not only to find and improve the technical vulnerabilities of the system but also to deliver a systematic approach in the system management to perform a successful second validation phase, in which the patients have to deal by themselves with the equipments. The outcome of phase A was the verification of the real life user requirements and the functional specifications of the system. In such a way, the CHRONIOUS platform was evaluated for its operational limitations and its capability for an increased efficacy and high usability scores. In more specifically, several issues have been identified and addressed, in particular concerning the design of the shirt in which a list of modifications has been finalized and the prototypes have been modified accordingly. The CHRONIOUS prototype has been enriched with its peripherals devices, and after that, the Phase B has started. During the current phase, that is the key point of CHRONIOUS validation, the system performance is evaluated in its final setting, patient’s home.
© Copyright 2008 Chronius project.
CHRONIOUS project is partially funded by the European Commission.